Biomarker Profiles Corporation, Leticia Cano , USA
Dr. Cano identified a native citrullinatedautoantigen for rheumatoid arthritis for her PhD dissertation. She did her postdoctoral training in the laboratory of Hank Fales at the National Institutes of Health, where she identified candidate biomarkers for Dermatomyositis, Juvenile Idiopathic ArthritisSystemic Lupus Erythematosis. As founder and president of Biomarker Profiles Corporation, she is interested in developing methods to increase the speed of biomarker discovery.
Biomarker discovery, clinical biomarkers, autoimmune disease, infectious disease, neurological disorders, rare disease, pain, bioinformatics, data mining, bioethics, automation, diagnostics